Abstract:Background: Accumulating evidence suggests that activated hepatocytes are involved in the deposition of the excess extracellular matrix during liver fibrosis via the epithelial to mesenchymal transition. Lipid accumulation in hepatocytes are implicated in the pathogenesis of chronic liver injury. CD36 is known to mediate long-chain fatty acid (LCFA) uptake and lipid metabolism. However, it is unclear whether LCFA directly promotes hepatocyte activation and the involved mechanisms have not been fully clarified. Methods: Mice were fed with a high fat diet (HFD) and normal hepatocyte cells (Chang liver cells) were treated with palmitic acid (PA) in vivo and in vitro. Real-time polymerase chain reaction (RT-PCR) and western blotting were used to examine the gene and protein expression of molecules involved in hepatic fibrogenesis and hepatocyte activation. CD36 was knocked down by transfecting CD36 siRNA into hepatocyte cells. Hydrogen peroxide (H2O2) and reactive oxygen species (ROS) levels were detected using commercial kits. Results: HFD induced a profibrogenic response and up-regulated CD36 expression in vivo. Analogously, PA increased lipid accumulation and induced human hepatocyte activation in vitro, which was also accompanied by increased CD36 expression. Interestingly, knockdown of CD36 resulted in a reduction of hepatocyte lipid deposition and decreased expression of Acta2 (34% decrease), Vimentin (29% decrease), Desmin (60% decrease), and TGF-β signaling pathway related genes. In addition, HFD and PA increased the production of H2O2 in vivo (48% increase) and in vitro (385% increase), and the antioxidant, NAC, ameliorated PA-induced hepatocyte activation. Furthermore, silencing of CD36 in vitro markedly attenuated PA-induced oxidative stress (H2O2: 41% decrease; ROS: 39% decrease), and the anti-activation effects of CD36 knockdown could be abolished by pretreatment with H2O2. Conclusions: Our study demonstrated that LCFA facilitates hepatocyte activation by up-regulating oxidative stress through CD36, which could be an important mechanism in the development of hepatic fibrosis.

The activated CD36-Src axis promotes lung adenocarcinoma cell proliferation and actin remodeling-involved metastasis in high-fat environment

CD36 Initiates Src Signal Transduction to Promote Actin Remodeling-Involved Metastasis of Lung Adenocarcinoma in High-Fat Environment

CD36 and Its Role in Regulating the Tumor Microenvironment

CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway

The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis

Fatty acid-induced CD36 expression via O-GlcNAcylation drives gastric cancer metastasis.

Cancer-associated Fibroblasts Contributed to Hepatocellular Carcinoma Recurrence and Metastasis Via CD36-mediated Fatty-Acid Metabolic Reprogramming.

Cd36 Mediates Palmitate Acid-Induced Metastasis Of Gastric Cancer Via Akt/Gsk-3/-Catenin Pathway

The fatty acid receptor CD36 promotes macrophage infiltration via p110γ signaling to stimulate metastasis

Targeting CD36 determines nicotine derivative NNK-induced lung adenocarcinoma carcinogenesis

Upregulation of CD36, a Fatty Acid Translocase, Promotes Colorectal Cancer Metastasis by Increasing MMP28 and Decreasing E-Cadherin Expression

CD36 Mediates Palmitate Acid-Induced Metastasis of Gastric Cancer Via AKT/GSK-3β/β-catenin Pathway

CD36: the Bridge Between Lipids and Tumors

HIF-2 alpha-induced upregulation of CD36 promotes the development of ccRCC

HIF-2α-induced Upregulation of CD36 Promotes the Development of Ccrcc.

Ccat1/Fabp5 Promotes Tumour Progression Through Mediating Fatty Acid Metabolism And Stabilizing Pi3k/Akt/Mtor Signalling In Lung Adenocarcinoma

Long-chain fatty acid activates hepatocytes through CD36 mediated oxidative stress

Fas Signaling in Adipocytes Promotes Low-Grade Inflammation and Lung Metastasis of Colorectal Cancer Through Interaction with Bmx.

Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway

HIF1A/PCDH7 axis mediates fatty acid synthesis and metabolism to inhibit lung adenocarcinoma anoikis

CDCA Attenuates LUAD Pathogenesis Progression Via Integrin Α5β1/fak/p53 Signalling Pathway